BioSpace News Archive

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Ixo-vec (ixoberogene soroparvovec), an investigational gene therapy for the treatment of wet AMD, an Innovation Passport under the Innovative Licensing and Access Pathway (ILAP).

Aquestive Therapeutics, Inc. today announced that it will report results for first quarter ended March 31, 2023, and provide an update on recent developments in its business after market close on Tuesday, May 2, 2023.

Spectral Medical Inc. today announced positive results in EUPHAS-2.

Femasys Inc. (NASDAQ: FEMY) today announced the Health Canada, the Public Health Agency of Canada, has granted product approval of FemaSeed®, the first-ever infertility solution designed to deliver sperm directly to where contraception occurs.

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today provided an update of results from the final multiple-dose cohort in the ongoing Phase 1a study of its investigational next-generation, highly potent hepatitis B virus (HBV) core inhibitor, ABI-4334.

HTG Molecular Diagnostics, Inc., a platform-based life science tools and drug discovery company, announced the achievement of three significant drug discovery business milestones in the first quarter of 2023.

Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces the acceptance of an oral presentation containing new data from the Company’s CC-42344 Phase 1 influenza A study at the 7th Annual International Society for Influenza and Other Respiratory Virus Diseases’ (ISIRV) Antiviral Group Conference.

Human Immunology Biosciences (HI-Bio™), today announced the appointment of Uptal Patel , M.D., as Chief Medical Officer.

Chiesi Global Rare Diseases announced a U.S. Networkwide Sponsorship of BioInnovation Labs, the leading developer and operator of life science coworking spaces with 12 active facilities and a growing network in the U.S. and internationally.

Remote patient monitoring (RPM) solutions leader Tenovi announced today that it is launching its cellular-enabled remote Peak Expiratory Flow Meter (PFM).